Outcome of myeloablative allogeneic peripheral blood hematopoietic stem cell transplantation for refractory/relapsed AML patients in NR status-Reference-Cited by-同舟云学术

Outcome of myeloablative allogeneic peripheral blood hematopoietic stem cell transplantation for refractory/relapsed AML patients in NR status

Published:2015-12 Issue:12 Volume:39 Page:1375-1381
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Liu Na^ORCID,Ning Hong-Mei,Hu Liang-ding,Jiang Min,Xu Chen,Hu Jiang-Wei,Wang Jun,Li Yu-Hang,Li Bo-tao,Lou Xiao,Yang Fan,Chen Jian-Lin,Su Yong-Feng,Li Meng,Wang Hong-ye,Ren Jing,Feng Yue-Qian,Zhang Bin,Wang Dan-hong,Chen Hu

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference27 articles.

1. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia;Zittoun;N. Engl. J. Med.,1995

2. HLA-identical sibling bone marrow transplants vs chemotherapy for acute myelogenous leukemia in first remission;Gale;Leukemia,1996

3. Factors affecting the outcome of allogeneic bone marrow transplantation for adult patients with refractory or relapsed acute leukaemia;Grigg;Br. J. Haematol.,1999

4. Allogeneic bone marrow transplantation for acute leukemia refractory to induction chemotherapy;Zander;Cancer,1985

5. Acute myeloid leukemia;Lowenberg;N. Engl. J. Med.,1999

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Allogeneic Stem Cell Transplantation in Refractory Acute Myeloid Leukaemia;Cells;2024-04-26

2. Pretransplantation predictors of survival in nonremission acute myeloid leukemia treated with haploidentical transplantation using steroid-based GVHD prophylaxis;Annals of Hematology;2024-02-23

3. Human mesenchymal stem cells derived exosomes inhibit the growth of acute myeloid leukemia cells via regulating miR-23b-5p/TRIM14 pathway;Molecular Medicine;2021-10-16

4. Allogeneic Hematopoietic Cell Transplantation for Adolescent and Young Adult Patients with Acute Myeloid Leukemia;Transplantation and Cellular Therapy;2021-04

5. Clinical Benefits of Preconditioning Intervention in Patients with Relapsed or Refractory Acute Myelogenous Leukemia Who Underwent Allogeneic Hematopoietic Cell Transplantation: A Kanto Study of Group for Cell Therapy Multicenter Analysis;Transplantation and Cellular Therapy;2021-01